There are also higher-dose versions of these medicines, such as Wegovy (semaglutide) and Zepbound (tirzepatide), that have been recently approved for weight loss alone
A 2021 study in The New England Journal of Medicine found that participants lost an average of 14.9% of their body weight in a 68-week period, compared to 2.4% lost without the medication
Compounded semaglutide is not FDA-approved, and its safety and effectiveness have not been established
At Balanced Medical Solutions, we have experience with managing GLP-1 treatment plans for patients in the San Francisco Bay Area and can offer guidance on overcoming a GLP-1 plateau
Experience a natural way to lose weight without doctor appointments, injections or side effects
Your provider reviews your lab results with you and explains whether GLP-1 therapy is appropriate, what the risks are in your case, and what the alternatives are if it is not